News for Healthier Living

Expanding HPV Vaccination to All Adults Aged 27-45 Years Unlikely to Be Cost-Effective or Efficient for HPV-Related Cancer Prevention

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than vaccinating younger people.

November 25, 2024


November 25 2024

November 24 2024

November 23 2024

November 22 2024

November 21 2024

November 20 2024

November 19 2024

November 18 2024

November 17 2024

November 16 2024

November 15 2024

November 14 2024

November 13 2024

November 12 2024